Multidrug-resistant tuberculosis: The problem and some priorities in controlling it

Area of Science:

• Public Health
• Infectious Diseases
• Microbiology

Background:

• Multidrug-resistant tuberculosis (MDR-TB) presents significant challenges and costs to national TB control programs globally.
• High prevalence of MDR-TB, reaching 50% in some areas, with a substantial proportion of new cases infected with resistant strains.
• Specific MDR-TB clones contribute significantly to the problem, particularly in high-burden regions.

Purpose of the Study:

• To highlight priority actions for controlling the spread of MDR-TB.
• To emphasize the importance of timely detection and prompt treatment adjustments for MDR-TB patients.
• To underscore the need for strengthened infection control and sustainable drug supply.

Main Methods:

• The study is a review and synthesis of current knowledge and strategies for MDR-TB control.
• It emphasizes the importance of early detection through diagnostic methods.
• It discusses the role of effective treatment regimens and infection control measures.

Main Results:

• Timely detection of resistant strains enables prompt changes to effective drug combinations, rendering patients noninfectious and promoting cure.
• Strengthened infection control measures are vital for limiting the transmission of resistant TB in healthcare settings and the community.
• Ensuring a sustainable drug supply is critical for uninterrupted treatment initiation and completion.

Conclusions:

• Effective MDR-TB control requires a multi-faceted approach including early detection, prompt treatment, robust infection control, and consistent drug supply.
• Special attention must be given to vulnerable populations, including immunocompromised individuals, prisoners, drug users, and migrants.
• Sustained political will and resource allocation are essential for implementing and maintaining effective drug-resistant TB control strategies.